Bleak new forecast for state’s battered cannabis industry
For several years, economists expected cannabis supply and demand to get into better balance, boosting pricing power. But it didn’t happen and now the forecast assumes continued low prices.
Kentucky medical cannabis industry reaches halfway mark with 24 dispensaries
Kentucky’s medical cannabis industry reaches a milestone as its 24th dispensary opens, with more than 24,000 patients, 407 industry jobs and growing statewide sales.
Labs, growers urge CCC to update pot testing rules
Cannabis businesses and others in the industry are urging regulators to update the state’s testing rules and make them more standardized and consistent with the latest data.
The Vault Is Still Locked: A Banking Update on Cannabis Rescheduling
There’s a scene near the end of every heist movie where the crew finally cracks the vault and it’s empty. Somebody already got there first, or …
Cannabis businesses call for updates to testing requirements
Cannabis businesses and others in the industry are urging regulators to update the state’s testing rules and make them more standardized and consistent with the latest data. The state’s cannabis …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Curaleaf’s hostile takeover bid for Aurora is just the tip of the iceberg for cannabis consolidation. These 2 stocks could be the biggest winners
After a huge gold rush, the marijuana sector stumbled, and now consolidation is gaining momentum.
5 Best Cannabis ETFs for 2026 and How to Invest
Discover the best marijuana ETFs to invest in, offering diversified exposure to the cannabis industry with growth potential and reduced risk.
Why Rescheduling Might Not Move Canopy Growth’s Stock as Much as You Think
Canopy Growth is a marijuana stock, but U.S. regulations aren’t the main driver of its business.
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.
Be careful before bucking the bearish trend.
Black Tie CBD Introduces Expert-Curated BudTender’s Choice THCA Flower Program
BROWNS SUMMIT, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) — Black Tie CBD today introduced its new BudTender’s Choice program, combining Certified Ganjier recommendations with flexible subscription options …
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo’s Optimized …
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses …
Will NYSE Composite Cannabis Stocks Extend Gains After CBD Shift?
Cannabis sector developments and NYSE Composite discussions intensified after federal CBD enforcement changes, highlighting hemp-derived products, wellness markets, and evolving regulatory frameworks.
TLRY stock back into the limelight – a look at the key developments that sparked investor optimism
The DEA rescheduling hearing that could reclassify marijuana is expected to be held on June 29. ・On Thursday, the Trump Administration pushed Congress to keep hemp CBD products legal by amending the …
Tilray Brands Inc (TLRY) Joins European Talks on Cannabis Regulations
Tilray Brands Inc (NASDAQ:TLRY) is one of the best CBD stocks to buy right now. Although Tilray Brands Inc (NASDAQ:TLRY) stock is up only a modest 19% over the past year, analysts see the stock …
Recent Comments